Regeneron Pharmaceuticals Inc (REGN)
800.00
-4.33
(-0.54%)
USD |
NASDAQ |
Nov 14, 11:37
Regeneron Pharmaceuticals Gross Profit (Annual): 11.30B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.30B |
| December 31, 2022 | 10.61B |
| December 31, 2021 | 13.63B |
| December 31, 2020 | 7.377B |
| December 31, 2019 | 5.792B |
| December 31, 2018 | 4.728B |
| December 31, 2017 | 5.475B |
| December 31, 2016 | 4.561B |
| December 31, 2015 | 3.711B |
| December 31, 2014 | 2.615B |
| December 31, 2013 | 1.949B |
| December 31, 2012 | 1.294B |
| December 31, 2011 | 441.61M |
| December 31, 2010 | 456.98M |
| December 31, 2009 | 377.58M |
| December 31, 2008 | 237.53M |
| December 31, 2007 | 125.02M |
| Date | Value |
|---|---|
| December 31, 2006 | 55.30M |
| December 31, 2005 | 56.64M |
| December 31, 2004 | 158.80M |
| December 31, 2003 | 50.82M |
| December 31, 2002 | 15.50M |
| December 31, 2001 | 15.46M |
| December 31, 2000 | 43.71M |
| December 31, 1999 | 30.90M |
| December 31, 1998 | 33.30M |
| December 31, 1997 | 24.30M |
| December 31, 1996 | 23.00M |
| December 31, 1995 | |
| December 31, 1994 | |
| December 31, 1993 | |
| December 31, 1992 | |
| December 31, 1991 | -5.50M |
| December 31, 1990 | -1.30M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
5.792B
Minimum
2019
13.63B
Maximum
2021
9.744B
Average
10.61B
Median
2022
Gross Profit (Annual) Benchmarks
| Amgen Inc | 19.74B |
| Eli Lilly and Co | 27.04B |
| Pfizer Inc | 33.54B |
| AbbVie Inc | 33.90B |
| Biogen Inc | 7.302B |